Skip to main content
. 2022 Apr 14;9(7):ofac193. doi: 10.1093/ofid/ofac193

Table 2.

Clinical Profile of 20 Patients With Periprosthetic Joint Infection Secondary to Corynebacterium spp.

Patient Age at PJI/Gender BMI Comorbidities Primary Arthroplasty Revision Micro at Prior PJIa Prior Suppressive ABX Time to PJI, mob Temporal Classification Micro at Current PJI No. of Specimens With Growth Specimen Type
1 79/M 25.8 CAD, chronic LLE ulcer L knee 25.7 Late C. striatum ≥2 SF/IO
2 91/M 32.2 CKD, obesity L knee Aseptic MIN 51.6 Late C. striatum ≥2 IO
3 60/M 32.3 DM, obesity R knee 0.5 Early C. striatum ≥2 IO
4 82/F 36 CAD, DM, CHF, PAD, CKD, obesity, R leg HL, R leg radiation therapy R knee Aseptic 94.3 Late C. striatum ≥2 SF
5 40/F 34.6 Teratologic right hip dislocation, obesity R hip Aseptic 0.6 Early C. amycolatum ≥2 SF/IO
6 59/M 62 CHF, obesity, RLE lymphedema R knee Septic-DAIR S. marcescens SXT 36.5 Late C. jeikeium 1 IO
7 75/M 36.4 CAD, obesity L knee Septic-2-stage CoNS 19.4 Late C. striatum ≥2 SF/IO
8 58/F 29.8 CKD R knee Septic-DAIR Negative MIN 11.8 Delayed C. striatum ≥2 SF/IO
9 65/F 37 Liver cirrhosis, DM, CHF, chronic RLE ulcer, CKD, obesity L knee 33.4 Late C. striatum 1 SFc
10 50/M 21.9 Klipperl-trenaunay syndrome, asplenia L knee 30.0 Late C. jeikeium 1 SF
11 59/M 42.4 CAD, DM, CHF, chronic LLE ulcer, CKD, obesity L knee Septic-DAIR MSSA LEX 31.8 Late C. striatum ≥2 SF/IO
12 63/F 20 RA, Crohn’s disease, immunosuppressive medications R hip Septic-DAIR P. mirabilis 30.4 Late C. striatum ≥2 IO
13 55/F 25.5 RA, Marfan syndrome, immunosuppressive medications R knee 12.2 Late C. jeikeium 1 IOd
14 69/M 32 Obesity L hip Aseptic 6.4 Delayed C. amycolatum ≥2 IO
15 68/F 33.5 RA, Sjogren syndrome, obesity R knee 13.3 Late C. jeikeium 1 IOd
16 57/M 31.3 DM, CKD, COPD, obesity, cerebellar ataxia, developmental delay L hip 9.7 Delayed C. striatum ≥2 SF/IO
17 85/M 27.9 CAD, DM, metastatic colon CA R knee 8.2 Delayed C. striatum ≥2 SF/IO
18 69/F 26.1 PAD, CKD, localized bladder CA, radiation to pelvis R hip 47.2 Late C. striatum ≥2 IO
19 65/M 42.8 DM, CIDP, immunosuppressive medications, obesity R knee Septic-DAIR C. striatum 20.7 Late C. striatum ≥2 SF/IO
20 51/F NR Breast CA R knee 5.2 Delayed C. striatum 1 SF

Abbreviations: ABX, antibiotics; BMI, body mass index; CA, cancer; CAD, coronary artery disease; CHF, congestive heart failure; CIDP, chronic inflammatory demyelinating polyneuropathy; CKD, chronic kidney disease; CoNS, coagulase-negative staphylococci; DAIR, debridement, antibiotic, and implant retention; DM, diabetes mellitus; F, female; HL, Hodgkin’s lymphoma; IO, intraoperative; L, left; LEX, cephalexin; LLE, left lower extremity; M, male; MIN, minocycline; MSSA, methicillin-susceptible Staphylococcus aureus; NR, not reported; PAD, peripheral arterial disease; R, right; RA, rheumatoid arthritis; RLE, right lower extremity; SF, synovial fluid; SXT, trimethoprim-sulfamethoxazole.

a

Stands for prior PJI episodes affecting the same joint as current PJI.

b

Time from last arthroplasty surgery to current PJI.

c

Growth from broth only.

d

Prosthesis sonicate fluid culture.